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A B S T R A C T
We evaluate a portable ultrasound and photoacoustic imaging (PAI) system for the feasibility of a point-
of-care assessment of clinically evident synovitis. Inﬂamed and non-inﬂamed proximal interphalangeal
joints of 10 patients were examined and compared with joints from 7 healthy volunteers. PAI scans,
ultrasound power Doppler (US-PD), and clinical examination were performed. We quantiﬁed the amount
of photoacoustic (PA) signal using a region of interest (ROI) drawn over the hypertrophic joint space. PAI
response was increased 4 to 10 fold when comparing inﬂamed with contralateral non-inﬂamed joints
and with joints from healthy volunteers (p < 0.001 for both). US-PD and PAI were strongly correlated
(Spearman’s r = 0.64, with 95% CI: 0.42, 0.79). Hence, PAI using a compact handheld probe is capable of
detecting clinically evident synovitis. This motivates further investigation into the predictive value of PAI,
including multispectral PAI, with other established modalities such as US-PD or MRI.
© 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
In rheumatoid arthritis (RA), imaging of synovitis with
ultrasound power Doppler (US-PD) and magnetic resonance
imaging (MRI) can predict disease progression and bone erosion
[1–3]. In clinical remission, detection of subclinical synovitis
indicates disease progression and increases the risk of disease ﬂare
[4–7]. US-PD has gained a place in the clinical workﬂow based on
these qualities. However, US-PD has inherently high operator
dependency and suboptimal reproducibility [8,9]. Speciﬁc com-
plications of US-PD are its dependency on the angle between the
ﬂow vector and the sound beam, and the disturbance of the blood
ﬂow by the probe pressure. MRI is rather costly, speciﬁcity is
modest and it requires contrast agents [10]. Optical imaging
methods were studied in recent years as potential alternatives.
Optical spectral transmission (OST) for example, has shown fair
performance at detecting synovitis while being presumably low in
cost [11–13], however, sensitivity and speciﬁcity are modest and
the low spatial resolution limits differentiation between synovitis
and tenosynovitis. Fluorescence optical imaging [14–17] appears to
have higher performance than OST, but also has low resolution and
in addition requires injection of contrast agents.
Photoacoustic imaging (PAI), a hybrid optical-and-ultrasound
imaging technique, may offer a good balance in features,
combining the sensitivity to haemoglobin of optical techniques
with the resolution of clinical ultrasound [18–21]. To form a PA
image, short laser pulses are shone on the skin and subsequently
enter the tissue, where the light is scattered by cells and becomes
diffuse. The light pulse is then absorbed by dark tissue constituents
such as haemoglobin and melanin. The absorption slightly heats
structures containing these constituents which leads to a small
pressure build-up, generating sound waves that can be picked up
by ultrasound transducers. PAI is therefore similar to sonography,
except that the ultrasound is generated within tissue, instead of
reﬂected ('backscattered') by it.
PAI differs signiﬁcantly from US-PD in three aspects. First,
movement of erythrocytes is not required for signal generation,
since the generation of PA signals relies only on the presence of
haemoglobin (or other chromophores) [19]. Second, there is a
larger concentration of haemoglobin within vasculature than in
surrounding tissue, leading to more signal generation, whereas in
US-PD, erythrocytes reﬂect comparatively less signal than the
surrounding tissue [22,23]. A wall ﬁlter is therefore not required in* Corresponding author.
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PAI, and ‘ﬂash' artefacts or motion clutter are not present. These
properties imply that slow blood ﬂow in synovial microvasculature
poses no problem to PAI. As a result, we expect PAI to be
particularly sensitive to subclinical synovitis. Finally, the PAI signal
is less affected by the orientation of the blood vessel than US-PD.
PAI has been investigated in other medical areas involving
angiogenesis, for instance in clinical studies into mammography
[24–27]. PAI has also been investigated in pre-clinical studies of
synovitis [28–31], and several setups have been proposed for
human ﬁnger joints [32–37]. In addition, a few early feasibility
studies have been performed with RA patients [38,39]. However,
these studies used large lasers, not suited for routine clinical
application, let alone point-of-care imaging.
In order to bring PAI to outpatient clinics, a handheld PA/US
probe was developed [33], which in this study is investigated for
possible use in assessing synovitis. The objective of this study is to
investigate whether this PA/US probe can detect clinically evident
synovitis and to compare the results with US-PD.
2. Methods
2.1. Patient inclusion
Patients undergoing care in the Ziekenhuisgroep Twente
hospital were asked by their rheumatologist to participate in this
study. Healthy volunteers were recruited in person or via ﬂyers at
the University of Twente.
Patients aged over 18 years with rheumatoid arthritis fulﬁlling 6
or more ACR/EULAR criteria (ACR/EULAR = American College of
Rheumatology/European League Against Rheumatism) were in-
cluded [40]. Speciﬁc inclusion criteria were: swelling of at least one
proximal interphalangeal (PIP) joint, 2, 3 or 4 joints with at least
grade 1 power-Doppler signal on US examination. Test subjects
(healthy or patient) were excluded from participation if they had
clinically signiﬁcant bone deformation and/or osteoarthritis in the
joint of interest. All subjects received written information and gave
informed consent, resulting in a delay of 3 to 8 days between the
inclusion by a rheumatologist and time of measurement.
2.2. Imaging system
The imaging study is performed using a dual modality
photoacoustic/ultrasound system. The system relies on a probe
that houses both a small diode laser together with ultrasound
transducers (see Fig. 1). The diode laser is pulsed to generate
photoacoustic waves, which are then detected by the ultrasound
transducers. These transducers are also used to transmit ultra-
sound to generate high-quality b-mode ultrasound images. The
probe in this study is a second generation prototype developed
from the probe described earlier in detail [33]. The original probe
contained diode lasers producing 130 ns pulses at a 805 nm
wavelength and a pulse energy of 0.56 mJ. As will appear, the main
change is a doubling of the pulse energy.
The diode laser source (Quantel Laser, les Ulis, France) is
controlled by a short pulse laser driver (Brightloop Converters,
Paris, France) and generates 1 mJ pulses of 120 ns duration. The
pulses are formed into a rectangular shape of 2.2 mm by 17.6 mm
(1/e2) by a diffractive optical element (SILIOS Technologies,
Peynier, France), after which the light exits the probe under an
angle via a prism. The laser emission is at 808 nm, which
corresponds to the isosbestic point of oxy-haemoglobin and
deoxy-haemoglobin, which leads to PA signal amplitudes inde-
pendent of the blood oxygenation.
The ultrasound detection is based on an ESAOTE SL3323 probe.
Transducers are placed in an array of 128 elements. Each element
has a bandwidth from 2.5 MHz to 10 MHz with a 7.5 MHz centre
frequency. An acoustic lens (focal length: 24 mm) is placed in front
of the transducers to moderately focus the detection in the
elevational plane.
The probe is connected to a MylabOne ultrasound scanner
(ESAOTE Europe), which can be used in two modes. In the ﬁrst it
transfers the collected time-pressure data from the middle 64
elements directly to a laptop. This mode is used to acquire
photoacoustic data. In the second mode the scanner operates
regularly and is used to acquire b-mode ultrasound using all 128
elements in a line-by-line transmission and acquisition scheme.
The US-PD examination is done using an identical MylabOne
scanner (in the second mode as described above) in combination
with a 14 MHz centre frequency linear array (SL3116, ESAOTE). The
PRF was set at 750 Hz, and the wall ﬁlter at its lowest and the
sensitivity at its highest setting.
2.3. Scan protocol
Per subject examination, a minimum of two PIP joints were
scanned: one clinically inﬂamed joint and an uninﬂamed joint –
preferably the same joint contra-lateral. A complete examination
of one subject included a series of longitudinal images using power
Doppler ultrasound for each applicable joint and another series
using the PA/US system. Both examinations took place with the
subject’s arm placed in a water bath ﬁtted with supports for the
arm, hand and the ﬁnger to be scanned (see Fig. 1). The water
temperature was controlled to 29–31 C during the examination.
During measurements there was no contact of the PA/US and US-
PD probes with the skin in order to avoid pressure artefacts. In
addition, the PA/US probe was placed 4–5 mm from the skin such
that the laser beam intersects with the ultrasound elevational
plane at the skin surface.
For the PA/US examination the PA/US probe was placed on a
motorized stage for better control of the measurement. The probe
Fig.1. The PA/US probe (left) with view of the front end showing the light delivery window (dark aperture) and acoustic lens in medium gray. The patient’s hand is submerged
in water (right) where it rests on a series of supports. The probe is mounted on a 2-axis motorized stage and positioned above the joint.
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was aligned longitudinal to the ﬁnger and on the dorsal side. The
stage was moved orthogonal to the ﬁnger in 0.5 mm steps for over
6 mm. At each step, a PA image was accumulated over 500 laser
pulses for 0.25 s. Taking into account the angle of incidence of 52
with the orthogonal on the skin and the beam size of 2.2 mm by
17.6 mm, the light exposure is 3.2 mW/cm2, which is below the IEC
60825-1 safety limit of 5 mW/cm2 for this wavelength and pulse
train. In addition, 100 frames of plane wave ultrasound (one ﬁxed
angle) were recorded each step. Each scan was repeated with the
same probe and at identical steps, but then with high-quality line-
by-line b-mode ultrasound. One scan yielded therefore 13 PA, 13
plane wave and 13 b-mode images at identical locations. In our
scan protocol there was approximately 1 min between a PA
acquisition and the subsequent b-mode US image.
US-PD examination was either performed by an experienced
rheumatologist or by placing the US-PD probe in the motorized
stage. For each joint, 3–5 images are recorded.
2.4. Scoring of US-PD images
Representative US-PD images were digitally stored and
anonymized. They were graded (0–3) according to Szkudlarek
et al. [40] by two rheumatologists who were blinded to the
allocation of the images. The widely used semi-quantitative
grading system is based on visual assessment of blood ﬂow as
indicated by power-Doppler signals: no signals (score 0), up to 3
single vessel signals (score 1), conﬂuent vessel signals in less than
half of the area of the synovium (2) or vessel signals in more than
half of the area of the synovium (3). Discrepant results were
reviewed to reach consensus resulting in a ﬁnal PD-score for each
individual joint.
2.5. Data analysis
The PA channel data – the pressure as a function of time as
measured by the transducers – is converted into a map of the
original pressure distribution using a Fourier domain reconstruc-
tion algorithm [41]. For this reconstruction algorithm, we found
an axial resolution of 0.2 mm and a lateral resolution of 0.4 mm
[33]. The algorithm was selected for its computational speed. All
data analysis is automated using Matlab (Massachusetts, USA). To
account for the light attenuation within tissue, a depth-
dependent correction ('gain') is applied. Since the ﬁnger in the
longitudinal orientation is fairly ﬂat, a basic exponential gain of
1=exp meffzð Þ is used with meff = 1/mm the effective attenuation
coefﬁcient and z the depth in tissue [42,43]. A different z = 0 is set
for every axial line in the PA image, such that the ﬂuence correction
starts at the skin level. Determining the position of the skin surface
was done visually using the PA response from the melanin layer in
the skin.
For image formation, the PA data is compressed logarithmically
at a dynamic range of 40 dB or 18 dB, with the same minimum and
maximum amplitude for inﬂamed and non-inﬂamed images.
These dynamic ranges were selected based on the noise level
(40 dB) and the amplitude of healthy joint’s background PA
signals (18 dB) respectively. Pixels within the dynamic range are
color coded in Matlab’s red-and-yellow color map ‘hot’ and ﬁnally
overlaid on a b-mode ultrasound image.
For each joint scan, a region-of-interest (ROI) is drawn to select
the hypertrophic joint area. The ROI is drawn on the b-mode
ultrasound image, where the hypertrophic area is deﬁned as to
include any pixels between the tendon and the bone surface. The
ROI is then transferred to the PA image, from which the number of
PA pixels is calculated that fall within the 18 dB dynamic range. A
secondary quantiﬁcation metric is provided by the mean
amplitude of non-compressed PA signals within the ROI. In case
of healthy joints there is no hypertrophic area and the ROI selection
will include more tissues than just the synovial space.
2.6. Statistical analysis
Mann-Whitney U-test (left-sided) is used for comparing the
control group (either joints from healthy volunteers or non-
inﬂamed joint from the same subject) with inﬂamed joints.
Spearman’s rank correlation is used when comparing the PD
grading with PA quantiﬁcation.
3. Results
3.1. Subject characteristics
7 healthy volunteers and 10 RA patients were included in the
study. All subjects had Caucasian skin. The characteristics of these
subjects are shown in Table 1. The RA patients had a mean disease
duration of 117 months (range 5–133), all were positive for
rheumatoid factors and 7 were positive for anti-cyclic-citrullinated
protein antibody (anti-CCP), and the mean C-reactive protein (CRP)
levels prior to the measurement were 6.3 (SD 5.6).
3.2. Photoacoustic/ultrasound imaging
Fig. 2 depicts examples of ﬂuence corrected PA/US and US-PD
images for an inﬂamed joint and the contra-lateral non-inﬂamed
joint of an RA patient. The reconstructed PA signals are shown
ranging from dark red (low signal amplitudes, starting at 40 dB)
to light yellow (high/abnormal signal amplitudes, up to 0 dB); the
data is overlaid on the grayscale US b-mode image. The PA images
in Fig. 2A show a superﬁcial blood vessel in both the inﬂamed and
non-inﬂamed joint, with additional PA features underneath, above
the bone surface. Larger amplitudes and more conﬂuent features
are recorded for the inﬂamed joint, as can be further observed in
Fig. 2B where only high amplitudes (18 dB dynamic range) are
plotted. With this threshold, almost no PA features are visible for
the non-inﬂamed joint.
3.3. Quantiﬁcation of PA and US-PD imaging
The numbers of high amplitude PA pixels (such as those visible
in Fig. 2B) were computed for inﬂamed and non-inﬂamed joints,
and of joints from healthy volunteers. The result (Fig. 3A) indicates
a larger number of high amplitude PA pixels for inﬂamed joints,
compared to healthy and non-inﬂamed joints. In addition, an
alternative quantiﬁcation method for PAI also shows a larger value
for inﬂamed joints: the mean (non-compressed) pressure ampli-
tude of PA features (Table 2). Both quantiﬁcation methods show 4
to 10-fold increased counts (p < 0.001) when comparing inﬂamed
joints with those from control groups. Note also that the ﬁngers are
swollen: the size of the ROI as drawn on the grayscale US images is
signiﬁcantly larger in inﬂamed joints compared to healthy
(p < 0.001) and compared to non-inﬂamed joints (p < 0.05).
Grading of US-PD images shows a strong agreement (r = 0.64,
95% CI: 0.42, 0.79, p < 0.001) of the PA pixel count with the
Table 1
Subject characteristics.
Characteristic Healthy volunteers RA patients
(N = 7) (N = 10)
Age: mean (range) 56 (49–62) 63 (49–80)
Gender (% female) 43% 50%
Values are the subject’s mean (standard deviation, SD) or (range).
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consensus PD score assigned to the images by two rheumatologists
(Fig. 3B and Table 3).
To obtain an early impression on the diagnostic accuracy of the
method, Receiver Operating Characteristics have been constructed
for the mean PA amplitude in the regions of interest, and the
number of high amplitude PA pixels, given in Fig. 4A and B,
respectively. Separate curves and areas under the curve are given
for inﬂamed joints vs. non-inﬂamed contralateral joints in patients,
and vs. joints in healthy subjects.
4. Discussion
We found that PAI – in the ﬁrst study with a handheld combined
photoacoustic probe – was sensitive to clinically evident synovitis
as demonstrated by the signiﬁcant difference in PA features
Fig. 2. PA/US and US/PD images of an inﬂamed (upper row) and non-inﬂamed contra-lateral joint (bottom row) of an RA patient. PA/US images in (A) show a difference in
color between inﬂamed and non-inﬂamed corresponding to an increase in amplitude levels. When discarding low PA amplitudes in (B), only features in the inﬂamed joint are
visible. Corresponding US-PD images are shown in (C). The blue line in the PA/US images indicates the ROI used for quantiﬁcation of PA features in the synovial space. The 0 dB
level is the maximum PA amplitude from the inﬂamed joint. d = dermis; dv = dorsal vein; pp = proximal phalanx; pip = proximal interphalangeal joint; mp = middle phalanx;
s = synovium; t = extensor tendon.
Fig. 3. PA quantiﬁcation with (A) comparing the number of high PA pixels for each joint group and (B) comparing the same quantiﬁcation for discrete PD score (0, 1, 2 or 3,
offset on the x-axis is to visualize individual markers); Spearman’s r = 0.64 (95% CI: 0.42, 0.79), p < 0.001. One triangle represents one joint and horizontal bar is median of one
group.
Table 2
PD score, PA quantiﬁcation and hypertrophic area (ROI size).
Parameter Healthy Non-inﬂamed Inﬂamed
(N = 12) (N = 11) (N = 11)
PD score 0.1 (0.3)*** 0.5 (0.7)** 1.7 (0.9)
Number of high PA pixels 225 (299)*** 444 (694)*** 2792 (1742)
Mean PA amplitude 13.2 (4.4)*** 14.9 (11.7)*** 56.7 (36.0)
ROI size (pixels) 4540 (1318)*** 7900 (3690)* 12468 (4554)
Quantiﬁcation values: mean (standard deviation). Rank test p-values for testing
inﬂamed joints versus either of the control groups (healthy or non-inﬂamed):
***p < 0.001, **p < 0.01 or *p < 0.05.
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between inﬂamed and control joints. In addition, the PA
quantiﬁcation agreed well with the corresponding semi-quantita-
tive PD scores. The ROCs and areas under the curve reveal a good
separation of photoacoustic image characteristics between in-
ﬂamed and non-inﬂamed joints. This observation must be treated
with care, because of the small size of the study and the
methodological limitations discussed below. Nevertheless, the
results do encourage further research in photoacoustic imaging of
early inﬂammations.
Hyper-vascularization and angiogenesis are hallmarks of
rheumatoid arthritis and are markers for imaging with US-PD,
as the increase in blood ﬂow is detectable using ultrasound ﬂow
imaging. In joints that are close to the skin, the increase in
vascularity is an attractive target for PAI. It should be realized, that
US-PD and PAI do not provide an identical representation of
vascularity, synovial or otherwise. On one hand, US-PD is expected
to highlight larger feeding vessels and, theoretically, the move-
ment of other structures such as villous synovial folds within the
hypertrophic region. On the other hand, PAI is expected to be
particularly sensitive to increased blood volume in smaller
vasculature within the synovial membrane. PAI typically works
best for small vessels, networked mostly parallel to the probe; US-
PD rather visualizes large vessels, angled to the probe. The unique
photoacoustic probe that we used in this study is sensitive to
vessels, or vascular networks of 0.2 mm in size and larger.
Interestingly, the appearance of synovitis in PAI is quite similar
for all the clinically inﬂamed joints that were imaged in this study
 unlike that of the US-PD representation, which varied
considerably.
These fundamental differences between PAI and US-PD may
help explain the variation between the PD score and the PAI
quantiﬁcation (Fig. 3B). There are a few data points that fall outside
the ‘natural’ spread: Fig. 3B shows two grade 1 joints with a very
high photoacoustic signal and three grade 1–2 joints that hardly
show a PAI signal. The former (“too high PAI signal”) may originate
from a different source, as the shape of these corresponding
structures was decidedly different from the regularly seen
representation of the synovium in PAI. The latter offsets (“too
low PAI signal”) may in fact be due to false positive PD scoring a
result of artefacts: notes from one of the two blinded examiners
conﬁrm this possibility.
While this work provides evidence of PAI detecting synovitis,
there exist a few methodological limitations to this study. For one,
the selection of patients took place approximately a week before
the PA examination. This may explain partly the variance in the PA
quantiﬁcation of inﬂamed joints (Fig. 3A), as some patients’
synovitis subsided after selection, but were still included in the
inﬂamed group. In addition, US-PD is hard to standardize, which
may have caused the PD artefacts explained earlier. Also, the
researcher in charge of drawing the ROIs was not blinded to the
joint inﬂammation, which may have biased the interpretation. This
issue was moderated however, since the ROI was drawn on the US
image without showing the PA overlay. A technical limitation of the
system was the inability to co-acquire high-quality b-mode and PA
images. The short delay between both may have resulted in
inaccuracy due to accidental movement of the ﬁnger. This
limitation of our setup will be solved in a future version, leading
to almost simultaneous acquisition of PA and b-mode US images.
Despite these limitations this study shows positive and highly
signiﬁcant ﬁndings in PAI. Fluence correction appeared to be
necessary in our analysis. Variations of the applied exponential
Table 3
PD score versus other parameters.
Parameter PD-0 PD-1 PD-2 PD-3
(N = 19) (N = 7) (N = 6) (N = 2)
Number of High PA pixels 252 (367) 2368 (2494) 1909 (1219) 2741 (472)
Mean PA amplitude 12.2 (4.1) 43.8 (39.8) 50.1 (38.8) 53.6 (6.5)
ROI size (pixels) 5263 (2115) 11075 (5265) 12162 (3868) 14013 (4445)
Quantiﬁcation values: mean (1s).
Fig. 4. Receiver Operating Characteristics (ROCs) for the mean PA amplitude (A) and the number of high PA pixels exceeding 18 dB (B) within the regions of interest. Separate
comparisons and areas under the curve are given of inﬂamed joints with joints in healthy subjects (‘healthy’) and contralateral joints in patients (‘control’).
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ﬂuence decay rate in a realistic interval around the assumed value
of 1/mm, had no critical inﬂuence on the outcome of our analysis.
This is the ﬁrst clinical study with a compact and fully
integrated PA/US imaging probe. It means an important step from
existing PAI systems, where sizable and costly external lasers are
used, towards practical use in clinical settings. Furthermore, our
system relies on a near infrared (NIR) light source at 808 nm, in
contrast to previous studies, which used visible light of 580 nm
[44]. While haemoglobin absorbs less NIR light than it does in the
visible range, light attenuation in the surrounding tissue is also
lower. This means that with NIR light the PA outcome depends less
on the exact tissue composition. In addition, absorption by
superﬁcial structures would be much more pronounced with
visible light, for instance in the melanin layer and of regular
vessels. Absorption like this is known to cause pronounced clutter
when these PA signals also travel down and reﬂect on lower
structures.
Previous studies showed that linear array-based systems such
as used in this study are susceptible to clutter and reﬂection
artefacts [45]. Future studies should therefore include clutter
reduction and artefact removal [46,47]. We were able to reject the
possibility of most types of artefacts by moving the illumination
position in relation to the ﬁnger – for most types of artefacts the
appearance of PA features would move in relation to the US image
[48], but this did not happen in the cases investigated here.
However, clutter may have caused the baseline PA signal as can be
seen in Fig. 2, and also some of the outlying data points in Fig. 3.
Future applications of PAI to synovitis can take advantage of its
multi-spectral imaging capabilities, allowing the estimation of the
oxygenation saturation (sO2) of the synovium. Multi-spectral PAI is
expected to improve the speciﬁcity of the technique. Targeted PA
contrast agents [49] with speciﬁc spectral signature linked to
molecular markers also deserve investigation, as they could
provide information about inﬂammation similar to for example
positron emission tomography. The next prototype of our probe
includes diode lasers of various wavelengths for this purpose. This
prototype merits further investigation of subclinical synovitis in a
larger patient population, and its predictive value for a disease
ﬂare. In addition, comparison with MRI angiography will allow a
closer look at which speciﬁc vascular structures are depicted by
PAI. A current limitation of the handheld probe is its low
penetration depth (15 mm) compared to other PAI systems, which
means future applications will likely focus on peripheral joints that
are close to the skin.
5. Conclusion
PAI is a unique modality due to its optical imaging contrast in
combination with ultrasound-based resolution. We have shown
that PAI with a handheld probe can detect clinically evident
synovitis, which is a ﬁrst step toward the application of PAI for
diagnosis and monitoring of inﬂammation in peripheral joints.
These results provide a basis for further research to investigate the
potential beneﬁts of PAI over other modalities.
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